Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,402.68
    -1,026.31 (-2.00%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

BUZZ-U.S. Stocks on the Move-Keryx, GlaxoSmithKline, Astrazeneca

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stock index e-mini futures fell on Monday: Dow Jones industrial average futures were down 0.15 percent at 17,091, S&P 500 futures were down 0.16 percent at 2,002.75 and Nasdaq 100 futures were down 0.11 percent at 4,082.

** KERYX BIOPHARMACEUTICALS INC (NasdaqCM: KERX - news) , Friday close $17.01, -4.59 pct premarket

Keryx Biopharmaceuticals won U.S. approval for its drug to lower phosphate levels in patients with chronic kidney disease (CKD), but the approval included an unexpected safety warning on the label.

** GLAXOSMITHKLINE PLC (Other OTC: GLAXF - news) , Friday close $47.92, -3.44 pct premarket

ADVERTISEMENT

An experimental Ebola vaccine similar to one being developed by GlaxoSmithKline is effective for at least five weeks in lab monkeys but requires boosting with an additional vaccine to extend its protection to 10 months, according to a study published on Sunday.

** ASTRAZENECA PLC (NYSE: AZN - news) , Friday close $74.74, -2.30 pct premarket

An experimental drug from AstraZeneca - part of a new wave of injectable respiratory drugs designed for people who do not respond adequately to traditional inhalers - has shown mixed results in chronic lung disease.

** GENERAL ELECTRIC CO, Friday close $26.1

** WHIRLPOOL CORP (NYSE: WHR - news) , Friday close $152.01

Sweden's AB Electrolux said it would buy General Electric's appliances business for $3.3 billion in cash to double sales in North America and take on rival Whirlpool in its biggest ever deal.

** BOEING CO (NYSE: BA - news) , Friday close $124.69

Boeing and Ryanair Holdings Plc (LSE: RYA.L - news) plan to make a significant fleet announcement on Monday, following reports last Friday that the low-cost Irish airline was poised to place a $10 billion order for Boeing's new 737 MAX jetliner.

** CARLYLE GROUP LP, Friday close $32.62

Carlyle Group, one of the world's largest private equity firms, said it had closed its fourth Asia fund at $3.9 billion, the second-largest private equity fund ever raised for Asia investments.

** FMC CORP (NYSE: FMC - news) , Friday close $65.6

Auriga Industries has agreed to sell its crop protection unit, Cheminova, to U.S.-based chemicals firm FMC for 10.5 billion Danish crowns ($1.8 billion), the Danish company said.

** WALGREEN CO (NYSE: WAG - news) , Friday close $63.95

The U.S. drugstore chain operator said it had appointed Barry Rosenstein of hedge fund Jana Partners to its board as the company moves to complete its takeover of drugstore chain Alliance Boots.

** GENERAL MOTORS CO, Friday close $34.58

The company will introduce in two years its first car that can communicate with other vehicles to help avoid accidents and ease traffic congestion, Chief Executive Mary Barra said on Sunday. (Reporting By Shubhankar Chakravorty in Bangalore; Editing by Simon Jennings)